Validity of ICU Clinician's Appraisal of Proportionality in CPR (VICAP-CPR)

June 10, 2025 updated by: University Hospital, Ghent
The VICAP-CPR study investigates whether doctors and nurses working in Intensive Care can determine neurological outcome and future quality of life after six months in patients treated for cardiac arrest outside the hospital based on clinical assessment in the first 24 hours after admission to Intensive Care. To conduct this study, the results of the questionnaire offered to Intensive Care doctors and nurses regarding the estimation of long-term neurological outcome and quality of life will be compared with the neurological outcome and quality of life as recorded in the STEPCARE study (NCT 05564754). The aim of the international STEPCARE study is to determine the best combination of post-resuscitation care to favourably influence survival and neurological outcome in patients treated for cardiac arrest outside hospital.

Study Overview

Status

Recruiting

Conditions

Detailed Description

In the guidelines 2021 of the European Resuscitation Council it is acknowledged that apart from criteria related to the cardiac arrest circumstances, additional criteria can be used to support resuscitation decisions. For instance, the presence of severe chronic comorbidities or a very poor quality of life prior to cardiac arrest are allowed to support decisions to stop or not start resuscitation in unwitnessed out-of-hospital cardiac arrest (OHCA) with an initial non-shockable rhythm. In current clinical practice, these factors are often not taken into account and patients with severe underlying comorbidities and poor general condition are also resuscitated. In intensive care, a wait-and-see approach is then usually adopted until additional information is gathered about the patient's likely prognosis based on repetitive clinical neurological examination, electrophysiological tests such as electro-encephalography and somatosensory evoked potentials, biomarker analysis and cerebral imaging (multimodal neuroprognostication).

At the ICU level, both physicians and nurses can have valuable insights into what the likely prognosis is of the OHCA patients they are treating. In subgroups with a poor prognosis (e.g. non-shockable unwitnessed arrest in older patient) the added value of the multimodal ICU neuroprognostication is potentially very limited or absent. The implication for intensive care could be that policy decisions could perhaps be made earlier in several situations. Exploring the prognostic value of the clinical perception of ICU physicians and ICU nurses regarding appropriateness of CPR and their prognostication of neurological outcome and quality of life relative to multimodal ICU neuroprognostication might help to refine the ethical guidance towards resuscitation decision making and towards ICU management after ROSC in general.

The study aims are:

  1. To assess whether and to what extent the following factors are associated with ICU clinician's perception regarding appropriateness of CPR: perceived presence of frailty, poor quality of life and severe comorbidities, as well as objective factors related to the OHCA (shockable rhythm, bystander CPR, witnessed arrest) and clinician characteristics (age, gender, years of experience and professional background).
  2. To assess the concordance between clinicians' combined perception of inappropriateness of CPR (i.e. whether or not at least 2 clinicians perceive CPR as inappropriate) and multimodal ICU neuroprognostication as performed in STEPCARE. The STEPCARE trial is an international, investigator-initiated, randomised trial on three different aspects of standard care after out-of-hospital cardiac arrest. In a 2x2x2 factorial design the effect of continuous sedation vs. minimal sedation, fever management with a device vs. without a device and a higher blood pressure target vs. a lower blood pressure target are compared. The primary outcome of the trial will be survival at 180 days with secondary outcomes including neurological function and health-related quality of life.
  3. To investigate the prognostic value of clinicians' combined perception of inappropriateness of CPR, the clinician's prognostication (functional outcome and quality of life after 6 months) and the added prognostic value of the multimodal ICU neuroprognostication with regard to the long-term composite outcome (alive with a good functional outcome and good quality of life as defined in STEPCARE) above and beyond the prognostic value of clinicians' combined perception of inappropriateness of CPR and the clinician's prognostication within subgroups of initial non-shockable/shockable rhythm.

Statistical analysis Associations between the perception of ICU physicians and ICU nurses regarding appropriateness of CPR, on the one hand, and the ICU clinician's perceived presence of frailty, severe comorbidities, quality of life, as well as objective factors related to the OHCA (shockable rhythm, bystander CPR, witnessed arrest) and clinician characteristics (age, gender, years of experience and professional background), on the other hand, will be estimated (in terms of conditional odds ratios) using a generalised linear mixed effects model (with 'logit' link and a random intercept for center and for patient) to allow statistical inference (estimation of corresponding standard errors and confidence intervals) that correctly accounts for the multilevel structure of the data (i.e. clinicians clustered within patients, patients clustered within centers).

Subsequently, the concordance between clinicians' combined perception of inappropriateness of CPR (A) and the result of the multimodal ICU neuroprognostication (Y) will be assessed by estimating the following predictive metrics with Y being the outcome and A being the predictor:

  • Positive Predictive Value (PPV)
  • Negative Predictive Value (NPV)
  • Sensitivity
  • Specificity
  • Area Under the Receiver-Operator Curve (AUC) The PPV expresses the percentage of poor multimodal ICU neuroprognostications among cases where at least two clinicians perceive CPR to have been inappropriate, while the NPV expresses the percentage of good multimodal ICU neuroprognostications among cases where less than two clinicians perceive CPR to have been inappropriate. Results of the multimodal ICU neuroprognostication will be imputed as 'good' or 'poor' whenever, respectively, patients were discharged alive or died before the multimodal ICU neuroprognostication could be conducted or completed. This enables calculation of the PPV and NPV in the population of patients originally included in the study and gives prospective insight into the extent to which clinicians' combined perception of inappropriateness of CPR in these patients is prognostic for the results of their multimodal ICU neuroprognostication. The sensitivity expresses the percentage of cases where at least two clinicians perceive CPR to have been inappropriate among poor multimodal ICU neuroprognostications, while the specificity expresses the percentage of cases where less than two clinicians perceive CPR to have been inappropriate among good multimodal ICU neuroprognostications. The latter two metrics will be calculated only in patients still hospitalized by the time the multimodal ICU neuroprognostication could be completed. This gives retrospective insight into the extent to which good or poor multimodal ICU neuroprognostication could already be anticipated by clinicians' combined perception of inappropriateness of CPR. Ideally, the multilevel nature of the data will be accounted for when estimating these metrics and their respective confidence intervals.

Subsequently, the prognostic value of clinicians' combined perception of inappropriate CPR and the clinician's prognostication with respect to the primary composite endpoint (alive with a good functional outcome and good quality of life as defined in STEPCARE) will be assessed in terms of the PPV, NPV and AUC. Additionally, the added or incremental prognostic value of the multimodal ICU neuroprognostication above and beyond that of ICU clinicians' combined perception of inappropriate CPR and the clinician's prognostication will be assessed in terms of increase in AUC. More specifically, two logistic regression model will be fitted: a logistic regression model for the primary outcome with clinicians' combined perception of inappropriate CPR, the clinician's prognostication as only predictor (model 1), and a logistic regression model for the primary outcome with clinicians' combined perception of inappropriate CPR, the clinician's prognostication and the result of the multimodal ICU neuroprognostication (and their interaction) as predictors (model 2). The AUCs of these models will be reported, as well as their respective PPV and NPV. AUC of model 2 minus AUC of model 1 will be estimated and used as a metric to quantify the added prognostic value. These analyses will be conducted for the entire study population, as well as in separate subgroups of patients with shockable versus non-shockable initial rhythms. For this analysis, whenever patients were discharged alive or died before the multimodal ICU neuroprognostication could be conducted or completed, results of the multimodal ICU neuroprognostication will be imputed in such a way that their coding is identical to that of the corresponding clinicians' combined perception of inappropriate CPR to reflect the fact that, in such cases, multimodal ICU neuroprognostication can by definition not have any added prognostic value. Ideally, the multilevel nature of the data will be accounted for when estimating these metrics and their respective confidence intervals.

The study will collect additional data apart from the STEPCARE study (NCT 05564754):

ICU doctors and nurses treating the patient in the first 24 hours after ICU admission are requested to complete a short (less than 3 minutes) survey, ideally as soon as possible since we are interested in the predictive value of clinical appraisal of the ICU doctor and ICU nurse.

The survey comprises questions regarding clinician characteristics, perception regarding frailty, quality of life, comorbidities, appropriateness of CPR and prognostication of the outcome 6 months after OHCA.

Study Type

Observational

Enrollment (Estimated)

1000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

The study population are doctors and nurses working in an Intensive Care Unit treating a patient included in the STEPCARE study (NCT 05564754) during the first 24 hours after admission to Intensive Care

Description

Inclusion Criteria:

  • Doctors and nurses working in the Intensive Care Unit treating patients included in the STEPCARE study (NCT 05564754)

Exclusion Criteria:

  • Doctors and nurses who do not have a direct treatment relationship with a patient included in the STEPCARE study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Nurses and doctors working in Intensive Care Units

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Composite endpoint of survival, good functional outcome and good quality of life 6 months after OHCA
Time Frame: 6 months after return of spontaneous circulation
Good functional outcome defined as modified Rankin scale 0 - 3; quality of life based on EuroQol-VAS
6 months after return of spontaneous circulation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Assessment of a likely poor neurological outcome based on the multimodal ICU neuroprognostication as performed in the Stepcare study NCT 05564754
Time Frame: More than 72 hours after randomisation in the Stepcare study NCT 05564754
Stepcare criteria for a likely poor neurological outcome are fulfilled yes or no
More than 72 hours after randomisation in the Stepcare study NCT 05564754

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University Hospital, Ghent

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 18, 2025

Primary Completion (Estimated)

December 30, 2026

Study Completion (Estimated)

December 30, 2026

Study Registration Dates

First Submitted

June 10, 2025

First Submitted That Met QC Criteria

June 10, 2025

First Posted (Actual)

June 18, 2025

Study Record Updates

Last Update Posted (Actual)

June 18, 2025

Last Update Submitted That Met QC Criteria

June 10, 2025

Last Verified

June 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • ONZ-2025-0119

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiac Arrest, Out-Of-Hospital

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Azerbaijan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe